title: Persistent hyperinsulinemic hypoglycemia of infancy: experience with 28 cases.
abstract: Twenty-eight infants with persistent hyperinsulinemic hypoglycemia of infancy (PHHI) were seen during a 10-year period. There were 13 males and 15 females. Their age at time of presentation ranged from a few hours to 6 months. Consanguinity was reported in 20 cases (71.4%). One family had two affected siblings and two affected cousins, another had three affected siblings and one affected cousin, and three others had lost siblings because of hypoglycemia and seizures. The primary clinical presentation was jitters and seizures in association with hypoglycemia. The diagnosis was suspected when the therapeutic glucose requirement was found to be more than 12 mg/kg/min and also when there was a good response to glucagon after exclusion of metabolic and storage diseases. A high insulin-to-glucose ratio was noted for all patients. Twenty-two had near-total (90%) pancreatectomy; the result was excellent in all but four, who required supplemental medical therapy. Five patients were treated medically, and one patient's family refused treatment. Twelve patients sustained moderate to severe brain injury before referral. There were no deaths, and only one patient had evidence of malabsorption after the pancreatectomy. PHHI correlates well with consanguinity and family history. Clinical awareness is essential to permit early diagnosis and prompt medical and supportive therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000284:Administration, Oral; D001925:Brain Damage, Chronic / Q000209:etiology; D003241:Consanguinity; D004564:Electrocoagulation / Q000009:adverse effects / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D005934:Glucagon / Q000008:administration & dosage / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006946:Hyperinsulinism / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D007003:Hypoglycemia / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D008286:Malabsorption Syndromes / Q000209:etiology; D008297:Male; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods; D012017:Referral and Consultation; D012640:Seizures / Q000175:diagnosis / Q000235:genetics; D016896:Treatment Outcome; D016312:Treatment Refusal
chemical_list: D005934:Glucagon; D005947:Glucose